Literature DB >> 25939811

The emerging molecular machinery and therapeutic targets of metastasis.

Yutong Sun1, Li Ma2.   

Abstract

Metastasis is a 100-year-old research topic. Technological advances during the past few decades have led to significant progress in our understanding of metastatic disease. However, metastasis remains the leading cause of cancer-related mortalities. The lack of appropriate clinical trials for metastasis preventive drugs and incomplete understanding of the molecular machinery are major obstacles in metastasis prevention and treatment. Numerous processes, factors, and signaling pathways are involved in regulating metastasis. Here we discuss recent progress in metastasis research, including epithelial-mesenchymal plasticity, cancer stem cells, emerging molecular determinants and therapeutic targets, and the link between metastasis and therapy resistance.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer stem cell; circulating tumor cell; epithelial–mesenchymal plasticity; metastasis; therapy resistance

Mesh:

Year:  2015        PMID: 25939811      PMCID: PMC4461477          DOI: 10.1016/j.tips.2015.04.001

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  126 in total

Review 1.  Metastasis to bone: causes, consequences and therapeutic opportunities.

Authors:  Gregory R Mundy
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  Perspective: The right trials.

Authors:  Patricia S Steeg
Journal:  Nature       Date:  2012-05-30       Impact factor: 49.962

3.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

Review 4.  Epithelial-mesenchymal transition and drug resistance: role, molecular mechanisms, and therapeutic strategies.

Authors:  Hua Sui; Lei Zhu; Wanli Deng; Qi Li
Journal:  Oncol Res Treat       Date:  2014-09-16       Impact factor: 2.825

Review 5.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

6.  A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

Authors:  P Mathijs Voorhoeve; Carlos le Sage; Mariette Schrier; Ad J M Gillis; Hans Stoop; Remco Nagel; Ying-Poi Liu; Josyanne van Duijse; Jarno Drost; Alexander Griekspoor; Eitan Zlotorynski; Norikazu Yabuta; Gabriella De Vita; Hiroshi Nojima; Leendert H J Looijenga; Reuven Agami
Journal:  Cell       Date:  2006-03-24       Impact factor: 41.582

7.  Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis.

Authors:  Nadja Dornhöfer; Suzanne Spong; Kevin Bennewith; Ali Salim; Stephen Klaus; Neeraja Kambham; Carol Wong; Fiona Kaper; Patrick Sutphin; Randall Nacamuli; Rendall Nacalumi; Michael Höckel; Quynh Le; Michael Longaker; George Yang; Albert Koong; Amato Giaccia
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

Review 8.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

9.  A cell-based small molecule screening method for identifying inhibitors of epithelial-mesenchymal transition in carcinoma.

Authors:  Kian-Ngiap Chua; Wen-Jing Sim; Victor Racine; Shi-Yun Lee; Boon Cher Goh; Jean Paul Thiery
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

10.  The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Authors:  K Aigner; B Dampier; L Descovich; M Mikula; A Sultan; M Schreiber; W Mikulits; T Brabletz; D Strand; P Obrist; W Sommergruber; N Schweifer; A Wernitznig; H Beug; R Foisner; A Eger
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more
  27 in total

Review 1.  Targeting dormant micrometastases: rationale, evidence to date and clinical implications.

Authors:  Robert E Hurst; Anja Bastian; Lora Bailey-Downs; Michael A Ihnat
Journal:  Ther Adv Med Oncol       Date:  2016-03       Impact factor: 8.168

Review 2.  MicroRNAs and metastasis: small RNAs play big roles.

Authors:  Jongchan Kim; Fan Yao; Zhenna Xiao; Yutong Sun; Li Ma
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

3.  USP37 is a SNAI1 deubiquitinase.

Authors:  Zhenna Xiao; Liang Chang; Jongchan Kim; Peijing Zhang; Qinglei Hang; Shannon Yap; Youming Guo; Zhicheng Zhou; Liyong Zeng; Xiaoyu Hu; Ashley Siverly; Yutong Sun; Li Ma
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

Review 4.  Naturally occurring compounds acting as potent anti-metastatic agents and their suppressing effects on Hedgehog and WNT/β-catenin signalling pathways.

Authors:  L Farahmand; B Darvishi; K Majidzadeh-A; A Madjid Ansari
Journal:  Cell Prolif       Date:  2016-09-27       Impact factor: 6.831

Review 5.  Cancer stem cells in human digestive tract malignancies.

Authors:  Fatemeh B Rassouli; Maryam M Matin; Morvarid Saeinasab
Journal:  Tumour Biol       Date:  2015-10-07

Review 6.  Epigenetic Therapeutics: A New Weapon in the War Against Cancer.

Authors:  Nita Ahuja; Anup R Sharma; Stephen B Baylin
Journal:  Annu Rev Med       Date:  2016       Impact factor: 13.739

7.  Withaferin A mitigates metastatic traits in human oral squamous cell carcinoma caused by aberrant claudin-1 expression.

Authors:  Ji-Ae Shin; Lee-Han Kim; Mi Heon Ryu; So-Young Choi; Bohwan Jin; WonWoo Lee; Yun Chan Jung; Chi-Hyun Ahn; Min-Hye Ahn; Kyoung-Ok Hong; Neeti Swarup; Kunal Chawla; Se Chan Kang; Seong Doo Hong; Sung-Dae Cho
Journal:  Cell Biol Toxicol       Date:  2021-03-04       Impact factor: 6.691

Review 8.  Medulloblastoma stem cells: Promising targets in medulloblastoma therapy.

Authors:  Guo-Hao Huang; Qing-Fu Xu; You-Hong Cui; Ningning Li; Xiu-Wu Bian; Sheng-Qing Lv
Journal:  Cancer Sci       Date:  2016-04-27       Impact factor: 6.716

9.  Identification of critical genes and gene interaction networks that mediate osteosarcoma metastasis to the lungs.

Authors:  Kegui Liu; Qunhui He; Guangjun Liao; Jian Han
Journal:  Exp Ther Med       Date:  2015-09-23       Impact factor: 2.447

10.  LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo.

Authors:  Long Chen; Huixin Yang; Yanbin Xiao; Xiaoxia Tang; Yuqian Li; Qiaoqiao Han; Junping Fu; Yuye Yang; Yuechun Zhu
Journal:  Onco Targets Ther       Date:  2016-07-04       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.